US Patent Issued to OP-T on June 9 for "CD154 peptides and methods of reducing inflammation" (Colorado Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,775, issued on June 9, was assigned to OP-T LLC (Aurora, Colo.). "CD154 peptides and methods of reducing inflammation" was invented by David... Read More

US Patent Issued to BEIJING WISDOMAB BIOTECHNOLOGY, GENRIX (SHANGHAI) BIOPHARMACEUTICAL, CHONGQING GENRIX BIOPHARMACEUTICAL on June 9 for "Antibody for tetanus toxin and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,777, issued on June 9, was assigned to BEIJING WISDOMAB BIOTECHNOLOGY Co. LTD (Daxing District, China), GENRIX (SHANGHAI) BIOPHARMACEUTICAL C... Read More

US Patent Issued to NANOPIN TECHNOLOGIES on June 9 for "Monoclonal antibodies and uses thereof" (Arizona, Louisiana Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,778, issued on June 9, was assigned to NANOPIN TECHNOLOGIES INC. (Gilbert, Ariz.). "Monoclonal antibodies and uses thereof" was invented by ... Read More

US Patent Issued to The Curators of the University of Missouri on June 9 for "Amyloid-beta antibodies" (Missouri Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,779, issued on June 9, was assigned to The Curators of the University of Missouri (Columbia, Mo.). "Amyloid-beta antibodies" was invented by... Read More

US Patent Issued to Nephris on June 9 for "Methods for treating diabetic kidney disease and glomerular disease" (American, Italian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,780, issued on June 9, was assigned to Nephris SrL (Milan). "Methods for treating diabetic kidney disease and glomerular disease" was invent... Read More

US Patent Issued to Novartis on June 9 for "Methods for treating diabetic retinopathy using brolucizumab" (Swiss Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,781, issued on June 9, was assigned to Novartis AG (Basel, Switzerland). "Methods for treating diabetic retinopathy using brolucizumab" was ... Read More

US Patent Issued to Horizon Therapeutics Ireland DAC on June 9 for "Immunocytokines for treatment of autoimmune and inflammatory conditions" (Maryland, Massachusetts Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,782, issued on June 9, was assigned to Horizon Therapeutics Ireland DAC (Dublin). "Immunocytokines for treatment of autoimmune and inflammat... Read More

US Patent Issued to IMMUNOMETABOLISM DEVELOPMENT on June 9 for "Anti-MCT1 antibodies and uses thereof" (American, Canadian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,783, issued on June 9, was assigned to IMMUNOMETABOLISM DEVELOPMENT Co. LLC (Lebanon, N.H.). "Anti-MCT1 antibodies and uses thereof" was inv... Read More

US Patent Issued to Oregon Health & Science University on June 9 for "Monoclonal antibodies for intracellular delivery of payloads" (Oregon Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,784, issued on June 9, was assigned to Oregon Health & Science University (Portland, Ore.). "Monoclonal antibodies for intracellular deliver... Read More

US Patent Issued to NATIONAL CANCER CENTER, PROTANBIO on June 9 for "Chimeric antigen receptor targeting BCMA and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,785, issued on June 9, was assigned to NATIONAL CANCER CENTER (Goyang-si, South Korea) and PROTANBIO INC. (Seoul, South Korea). "Chimeric an... Read More

• ««
• «
• 29597
• 29598
• 29599
• 29600
• 29601
• 29602
• 29603
• 29604
• 29605
• 29606
• »
• »»